Stay updated on Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial page.

Latest updates to the Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.8.1 instead of v3.8.0, with no apparent change to the study record.SummaryDifference0.1%

- Check10 days agoChange DetectedThe record presents a Phase II study comparing fruquintinib plus raltitrexed with fruquintinib alone for advanced colorectal cancer, including its eligibility criteria, treatment arms, outcomes, and study location.SummaryDifference47%

- Check17 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check31 days agoChange DetectedA site-wide NIH notice announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition period. The footer revision identifier advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check45 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1. The page remains a 403 error page without study details.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content. This makes the study information on this page inaccessible to users.SummaryDifference18%

Stay in the know with updates to Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial page.